Document Detail


Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy.
MedLine Citation:
PMID:  20089774     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Lactic acid bacteria and bifidobacteria are increasingly being administered to pregnant women and infants with the intention of improving health. Although these organisms have a long record of safe use, it is important to identify any adverse effects in potentially vulnerable populations. In a randomized, double-blinded, placebo-controlled trial, we evaluated the safety of a bacterial dietary supplement for the prevention of atopy in infants. Two strains of lactobacilli (Lactobacillus salivarius CUL61 and Lactobacillus paracasei CUL08) and bifidobacteria (Bifidobacterium animalis subsp. lactis CUL34 and Bifidobacterium bifidum CUL20) with a total of 1 x 10(10) colony-forming units were administered daily to women during the last month of pregnancy and to infants aged 0-6 mo. Adverse events (AE) were classified according to WHO International Statistical Classification of Diseases criteria. Common symptoms were recorded by regular questionnaires. Baseline characteristics of 220 mother-infant dyads in the treatment and 234 in the placebo group were similar. Compliance with the trial interventions, loss to follow-up, symptoms, drug usage, infant growth, method of feeding, visits to the doctor, and mothers' assessment of infant health were similar in the 2 groups. Fifteen (6.8%) mothers and 73 (33.2%) infants in the treatment group and 21 (9.0%) mothers and 75 (32.1%) infants in the placebo group reported AE (P = 0.49 and P = 0.84, respectively). Severe AE occurred in 18 mothers and 63 infants with a similar frequency in each group. None of the AE were attributed to the intervention. Our findings support the safe use of this consortium of organisms during pregnancy and early infancy.
Authors:
Stephen J Allen; Susan Jordan; Melanie Storey; Catherine A Thornton; Michael Gravenor; Iveta Garaiova; Susan F Plummer; Duolao Wang; Gareth Morgan
Related Documents :
2494024 - Effects of formal support on mothers' adaptation to the hospital-to-home transition of ...
12395564 - Observing mother-child relationships across generations: boundary patterns, attachment,...
8034814 - Child custody mediation and litigation: parents' satisfaction and functioning one year ...
8918104 - Infanticide in scotland.
7129734 - Mortality from malignant melanoma in australia: effects due to country of birth.
22542294 - Carcinogenic polycyclic aromatic hydrocarbons in umbilical cord blood of human neonates...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial     Date:  2010-01-20
Journal Detail:
Title:  The Journal of nutrition     Volume:  140     ISSN:  1541-6100     ISO Abbreviation:  J. Nutr.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-02-22     Completed Date:  2010-03-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0404243     Medline TA:  J Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  483-8     Citation Subset:  IM    
Affiliation:
The School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, Wales, UK. s.j.allen@swansea.ac
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Bifidobacterium*
Dietary Supplements / adverse effects*
Double-Blind Method
Female
Humans
Hypersensitivity, Immediate / prevention & control*
Infant
Infant, Newborn
Lactobacillus*
Pregnancy
Pregnancy Trimester, Third
Probiotics / administration & dosage,  adverse effects*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Isoleucine Prevents the Accumulation of Tissue Triglycerides and Upregulates the Expression of PPAR{...
Next Document:  Early Weaning Reduces Small Intestinal Alkaline Phosphatase Expression in Pigs.